These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 29669668

  • 21. STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD® ) Device, in Healthy Adult Subjects.
    Shrewsbury SB, Jeleva M, Satterly KH, Lickliter J, Hoekman J.
    Headache; 2019 Mar; 59(3):394-409. PubMed ID: 30659611
    [Abstract] [Full Text] [Related]

  • 22. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S, Jang IJ, Shin D, Shin DS, Yoon S, Lim KS, Yu KS, Li J, Zhang H, Liu Y, Brendel E, Blode H, Wang Y.
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
    Vaidya S, Ziegler D, Tanase AM, Malmqvist U, Kanniess F, Hederer B, Hosoe M.
    Pulm Pharmacol Ther; 2021 Oct; 70():102019. PubMed ID: 33771722
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.
    Amini E, Berger SM, Schilling U, Jiao Y, Chen MJ, Bachhav S, Baumstein SM, Tang Y, Al-Humiari M, Leon Astudillo CE, Drescher S, Iley T, Shur J, Price R, Carrasco C, Conti DS, Delvadia R, Oguntimein O, Witzmann K, Absar M, Luke MC, Boc S, Dhapare S, Saluja B, Bielski E, Newman B, Bulitta JB, Hochhaus G.
    Mol Pharm; 2023 Nov 06; 20(11):5690-5700. PubMed ID: 37773975
    [Abstract] [Full Text] [Related]

  • 25. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T, Hubbell J, Cutler DL, Johnson-Levonas AO, Xu D, Kantesaria BS, Kim K, Miller SD.
    Chest; 2013 Dec 06; 144(6):1795-1802. PubMed ID: 24077095
    [Abstract] [Full Text] [Related]

  • 26. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
    Henney HR, Sperling MR, Rabinowicz AL, Bream G, Carrazana EJ.
    Epilepsy Res; 2014 Sep 06; 108(7):1204-11. PubMed ID: 24934774
    [Abstract] [Full Text] [Related]

  • 27. A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol.
    Messina JC, Offman E, Carothers JL, Mahmoud RA.
    Clin Ther; 2019 Nov 06; 41(11):2343-2356. PubMed ID: 31732149
    [Abstract] [Full Text] [Related]

  • 28. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb 06; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 29. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
    Patel D, Garadi R, Brubaker M, Conroy JP, Kaji Y, Crenshaw K, Whitling A, Wall GM.
    Allergy Asthma Proc; 2007 Feb 06; 28(5):592-9. PubMed ID: 18034980
    [Abstract] [Full Text] [Related]

  • 30. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy.
    Ghafar MHA, Mohamed H, Mohammad NMY, Mohammad ZW, Madiadipoera T, Wang Y, Abdullah B.
    Acta Otorrinolaringol Esp (Engl Ed); 2020 Feb 06; 71(3):147-153. PubMed ID: 31400807
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C, Stark JG, McMahen R, Engelking D.
    Clin Ther; 2017 Dec 06; 39(12):2389-2398. PubMed ID: 29174216
    [Abstract] [Full Text] [Related]

  • 32. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF, Poo JL, Maya-Barrios JA, de Lago A, Oliva I, González-de la Parra M, Jiménez P, López-Bojórquez E, Burke-Fraga V, Namur S.
    Clin Ther; 2008 Sep 06; 30(9):1667-74. PubMed ID: 18840372
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers.
    Kale P.
    Front Pharmacol; 2014 Sep 06; 5():98. PubMed ID: 24847268
    [Abstract] [Full Text] [Related]

  • 34. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R, Mometasone Furoate Nasal Spray With Loratadine Study Group.
    Ann Allergy Asthma Immunol; 2008 Mar 06; 100(3):264-71. PubMed ID: 18426147
    [Abstract] [Full Text] [Related]

  • 35. [The effectiveness of the combination of azelastine hydrochloride and mometasone furoate for the intranasal application in the patients presenting with seasonal allergic rhinitis].
    Karpishchenko SA, Kolesnikova OM.
    Vestn Otorinolaringol; 2017 Mar 06; 82(5):44-47. PubMed ID: 29072663
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study.
    Ratner PH, Melchior A, Dunbar SA, Tantry SK, Dorinsky PM.
    Clin Ther; 2012 Jun 06; 34(6):1422-31. PubMed ID: 22621776
    [Abstract] [Full Text] [Related]

  • 37. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C.
    Eur J Clin Pharmacol; 2004 Jun 06; 60(4):265-8. PubMed ID: 15114430
    [Abstract] [Full Text] [Related]

  • 38. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K, Schnell D, Jungnik A, Ring A, Theodor R, Hohl K, Meinicke T, Friedrich C.
    Int J Clin Pharmacol Ther; 2014 Jul 06; 52(7):549-63. PubMed ID: 24755124
    [Abstract] [Full Text] [Related]

  • 39. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
    Yonezaki M, Akiyama K, Karaki M, Goto R, Inamoto R, Samukawa Y, Kobayashi R, Kobayashi E, Hoshikawa H.
    Auris Nasus Larynx; 2016 Jun 06; 43(3):292-7. PubMed ID: 26498699
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study.
    Shimada S, Vaidya S, Khindri S, Tashiro N, Cheng Y, Hara H, Majumdar T, Woessner R, Furihata K, Kobayashi K.
    Int J Clin Pharmacol Ther; 2015 May 06; 53(5):398-407. PubMed ID: 25740265
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.